Gabrielle Emanuel
[Copyright 2024 NPR]
-
A year ago, the WHO and Africa CDC triggered the highest health alert for the mpox outbreak. experts say the response has been an indicator of how poorly prepared the world is for a future pandemic.
-
A year ago, on Aug. 14, 2024, the World Health Organization declared mpox a Public Health Emergency of International Concern. Why are health experts so frustrated by the world's response?
-
It's the 40th anniversary of the superstar concert to raise money for the famine in Ethiopia — and of the creation of a U.S. program called FEWS NET to prevent future famines.
-
After the U.S. early famine warning systems went dark earlier in 2025, the lights are back on. But questions remain about whether it will be as effective as before and whether it will be politicized.
-
The therapeutic food is designed to bring malnourished kids back from the brink. A new order from the U.S. after months of mixed signals is good news for the Rhode Island factory that makes it.
-
Charities usually like to talk to the public about their good works. In the wake of the Trump aid cuts, there's a new approach: "anticipatory silence." It's controversial.
-
Founded by George W. Bush, the President's Emergency Plan for AIDS Relief was taken out of the list of agencies that lost previously pledged funds. But its future is far from certain.
-
When Congress approved a Trump administration plan to take back $9 billion in funds they'd previously allocated to public media and foreign aid, there was just one program that lawmakers decided to spare: The U.S.'s HIV/AIDS initiative or PEPFAR. Does that mean PEPFAR will return to its original role leading the world's HIV/AIDS response? Radio ran on ATC on Wednesday. DIgital for Thursday, hope to publish by 2 p.m.
-
It costs nearly $100 million a year to maintain global stockpiles of vaccines for Ebola, cholera, meningitis and yellow fever in case of emergency. A new study estimates how many lives they've saved.
-
RFK Jr. stunned the global health world when he said the U.S. would halt funding the group that helps provide vaccines to many low-income countries. The study he cited is seen by others as dubious.